These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1349553

  • 1. Short- and long-term management of peptic ulcer disease: current role of H2-antagonists.
    Brooks WS.
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():47-52. PubMed ID: 1349553
    [Abstract] [Full Text] [Related]

  • 2. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC, Lee CL, Chan CC, Tu TC, Liao CC, Wu CH, Chen TK.
    Arch Intern Med; 2003 Sep 22; 163(17):2020-4. PubMed ID: 14504114
    [Abstract] [Full Text] [Related]

  • 3. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Kodama M, Fujioka T.
    J Gastroenterol Hepatol; 2006 Jun 22; 21(6):1048-53. PubMed ID: 16724993
    [Abstract] [Full Text] [Related]

  • 4. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM, Carballo F, Blanco M.
    Hepatogastroenterology; 1992 Feb 22; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M, Tsuda M, Okita K, Sugiyama T, Nakazawa T.
    Eur J Gastroenterol Hepatol; 1995 Aug 22; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [Abstract] [Full Text] [Related]

  • 6. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 Aug 22; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 7. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J, Börsch G.
    Am J Gastroenterol; 1994 Oct 22; 89(10):1785-8. PubMed ID: 7942667
    [Abstract] [Full Text] [Related]

  • 8. [Drug therapy of peptic ulcer in the elderly].
    Koop H.
    Z Gerontol; 1992 Oct 22; 25(5):304-8. PubMed ID: 1359717
    [Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
    Allison JE, Hurley LB, Hiatt RA, Levin TR, Ackerson LM, Lieu TA.
    Arch Intern Med; 2003 May 26; 163(10):1165-71. PubMed ID: 12767952
    [Abstract] [Full Text] [Related]

  • 10. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
    Jost C, Marbet UA.
    Schweiz Med Wochenschr; 1998 Jan 17; 128(3):64-71. PubMed ID: 9498257
    [Abstract] [Full Text] [Related]

  • 11. Peptic ulcer disease: what is the role for Helicobacter pylori?
    Bourke B, Sherman P, Drumm B.
    Semin Gastrointest Dis; 1994 Jan 17; 5(1):24-31. PubMed ID: 7915181
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec 17; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Muñoz E.
    Aliment Pharmacol Ther; 2004 Mar 15; 19(6):617-29. PubMed ID: 15023164
    [Abstract] [Full Text] [Related]

  • 14. Long-term consequences of Helicobacter pylori eradication: clinical aspects.
    Labenz J, Tillenburg B, Peitz U, Börsch G.
    Scand J Gastroenterol Suppl; 1996 Mar 15; 215():111-5. PubMed ID: 8722393
    [Abstract] [Full Text] [Related]

  • 15. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul 15; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 16. [Management of the peptic ulcer patient in the Helicobacter pylori age].
    Marshall BJ.
    Enferm Infecc Microbiol Clin; 1994 May 15; 12 Suppl 1():36-40. PubMed ID: 7914434
    [No Abstract] [Full Text] [Related]

  • 17. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T, Uribe RU, Kubota T, Murakami K, Kawasaki H, Nasu M.
    Eur J Gastroenterol Hepatol; 1995 Aug 15; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [Abstract] [Full Text] [Related]

  • 18. Eradication treatment for Helicobacter pylori in general practice.
    Fraser AG, Moore L, Berry S, Arroll B.
    N Z Med J; 1996 Nov 08; 109(1033):422-4. PubMed ID: 8941293
    [Abstract] [Full Text] [Related]

  • 19. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
    Lai KC, Hui WM, Wong WM, Wong BC, Hu WH, Ching CK, Lam SK.
    Am J Gastroenterol; 2000 Sep 08; 95(9):2225-32. PubMed ID: 11007222
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori and peptic ulcer disease.
    Feldman M, Peterson WL.
    West J Med; 1993 Nov 08; 159(5):555-9. PubMed ID: 8279151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.